Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2045 Perioperative Outcomes of Surgery for Pancreatic Neuroendocrine Neoplasms in Germany
Introduction: The incidence of pancreatic neuroendocrine neoplasms(pNEN) is increasing and the perioperative outcomes of specialized centers are favourable.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Mintziras I, Werner J, Keck T, Hommann M, Germer C,
Keywords: pancreatic neuroendocrine neoplasms, surgical resection, StuDoQ|pancreas registry,
Introduction: According to ENETS guidelines small(<2cm) pNEN should be operated laparoscopically with parenchyma-sparing resection without formal lymphadenectomy.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Mintziras I, Werner J, Keck T, Hommann M, Germer C,
Keywords: small (<2cm) pancreatic neuroendocrine tumors, surgical resection, StuDoQ|pancreas registry,
Introduction: The theranostic twins [68Ga]Pentixafor and [177Lu]Pentixather for chemokine-directed endoradiotherapy (ERT) were recently developed.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Werner R
Authors: Werner R, Weich A, Higuchi T, Schmid J, Schirbel A,
Keywords: Neuroendocrine tumor, [68Ga]Pentixafor, CXCR4, PRRT, PET/CT,
Introduction: Given its neuroendocrine origin, the prognosis of medullary thyroid carcinoma (MTC) remained poor in common chemotherapeutic approaches. However, the encouraging results of tyrosine kinase inhibitors (TKI) such as vandetanib emphasize the high demand for selecting appropriate candidates.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Werner R
#1545 In Vivo Expression of Survivin and XIAP in Medullary Thyroid Carcimoma
Introduction: Medullary thyroid carcinoma (MTC) accounts for approximately 5 % of all thyroid malignancies. Although surgery remains the first line therapy with curative intention, for advanced MTC current chemotherapeutic regimes do not provide promising results. Consequently, the identification of biologically relevant biomarkers that are associated with MTC progression may provide novel therapeutic targets.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Werner T